Share the Video:

Psychedelics, addiction, and recovery

PS2023Harm ReductionIntegrationPolicy and AdvocacyPsychedelic Assisted TherapyResearchSubstance Use Disorder

Kevin Franciotti, Reilly Capps, Celeste Alvarez, Danielle Nova, Rick Barnett, Juliana Mulligan

While psychedelic-assisted therapy has been studied since the 1950s as a treatment for addictive disorders and were even admired by Bill W, the founder of Alcoholics Anonymous, most peer support groups do not understand how psychedelic-assisted therapy differs from “drug use”. Join us for a discussion of how support, sobriety, recovery, and psychedelics can be harmonized.

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Related Videos

PS2023Harm ReductionIntegrationPolicy and AdvocacyPsychedelic Assisted TherapyPsychedelic ScienceResearch

Responding to Crises and Calls with Psychedelic Harm Reduction

Panelists from Zendo Project, Fireside Project, Kosmicare, and Anashim Tovim discuss harm reduction strategies in the psychedelic ecosystem, emphasizing innovation, compassion, and scientific expertise in diverse settings. They provide case

Joshua White, Daniel E Martin, Pinni Baumol, Shirelle Noble, Ben Halper

PS2023Harm ReductionPolicy and AdvocacyPsilocybinPsilocybin-assisted therapyPsychedelic Assisted TherapyResearchSubstance Use Disorder

Psilocybin Treatment of Tobacco Addiction: From a Wing and a Prayer to Federally Funded Psychedelic Therapy Research

Psilocybin research journey: investigating its use for treating tobacco addiction. Includes pilot study, comparative efficacy study, and upcoming multi-site clinical trial funded by NIDA.

PS2023IntegrationPolicy and AdvocacyPsychedelic Assisted TherapyPsychedelic ScienceResearchResources for Therapists

Improving study design in trials using psychedelic-assisted therapies

Psychedelic research faces challenges balancing methodological rigor with preserving subjective experiences in clinical trials, aiming to avoid bias while capturing the full impact of psychedelics on participants.

Ingmar Gorman, Erika Dyck, Tehseen Noorani

PS2023IntegrationPolicy and AdvocacyPsychedelic Assisted TherapyPsychedelic ScienceResearchSocial and Cultural

Psychedelic Outcomes: Intersection of Environment, Self-Identity, and Success ( The POIESIS Study)

The POIESIS study explores how self-identity dimensions influence preferences in a psychedelic dosing environment. Initial findings show stronger connections to spiritual/religious identity compared to racial/ethnic identity. Ongoing efforts aim to

Cody J Wenthur

PS2023Harm ReductionHealth ConditionsPolicy and AdvocacyPsychedelic ScienceResearchSubstance Use Disorder

The Canadian Psychedelic Survey; Results of a Large Cross-Sectional Survey of Canadian Adults Who Use Psychedelics

Canadian Psychedelic Survey collected real-world evidence from 2393 Canadian adults on psychedelic use, revealing patterns, effects, and reasons for use. Results may influence policy and treatment approaches.

Philippe Lucas

PS2023IntegrationKetaminePolicy and AdvocacyPsychedelic Assisted TherapyPsychedelic ScienceResearch

Building the next generation of psychedelic retreat centers

Psychedelic retreat centers are operating worldwide, with Oregon and Colorado preparing to regulate similar centers. These venues offer access to psychedelic experiences outside clinical settings, raising questions about their differences

Alexandra Pallas, Melissa Stangl, Ann “Annie Oak” Harrison

PS2023Harm ReductionPsilocybinPsychedelic Assisted TherapyResearchSubstance Use Disorder

Effects of Psilocybin in Alcohol Use Disorder: Beyond Reduction

Dr. Bogenschutz presents quantitative findings from a psilocybin trial for alcohol use disorder, showing reduced alcohol craving and improved mood and cognition. Dr. Agin-Liebes discusses qualitative results on self-awareness and

Gabrielle Agin-Liebes

PS2023Harm ReductionIntegrationPsychedelic Assisted TherapyPsychedelic ScienceSocial and CulturalTherapy Ethics

Sex and Psychedelics: Weaving Altered States for Healing and Pleasure

Britta Love, Laura Mae Northrup, and Leticia Brown explore the intersection of sex and psychedelics, discussing consent, altered consciousness, and enhancing erotic experiences through psychedelics.

Leticia Brown, Monica Cadena, Laura Mae Northrup, Britta Love

PS2023IntegrationPsychedelic Assisted TherapyPsychedelic ScienceResearchResources for Therapists

The Legacy of Stanislav Grof

Stanislav Grof, a pioneer in psychedelic research, presents the Grof® Legacy Training on 'holotropic' states of consciousness, with colleagues from international psychedelic training programs.

Brigitte Grof, Stanislav Grof, Diane Haug, Javier Charme, Neil Hannon, Jay Dufrechou